Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

Completed

Conditions studied: Long COVID-19, Acute COVID-19, Postural Orthostatic Tachycardia Syndrome (POTS), Diabetic Neuropathy

In brief

This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.

Key facts

Study ID

NCT07005947

Run by

CND Life Sciences

People needed

237

Starts

2023-11-30

Expected to finish

2026-06-30

Last updated by the study team

2026-07-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Clinical evidence of severe peripheral vascular disease
• History of ulceration, poor wound healing or vascular claudication
• History of allergic reaction to local anesthesia (for biopsy collection)
• Use of oral anticoagulants (aspirin or Plavix alone is allowed)
• History of a bleeding disorder

Where it is running

• CND Life Sciences — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.